에 대한 최신 뉴스 PHI Group (OTC:PHIG) 주식

PHI Group Inc is part of the financial services industry. Its primary scope of business is mergers and acquisitions. Its M&A advisory and consulting services include strategic and transaction advisory and consulting services related to acquisitions and divestitures. It advises and consults with buyers and sellers of businesses, provides corporate restructuring and turnaround management services, and delivers post-closing value enhancement services.

Equities

News

Markets

DLTR

FTAI

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HOOD

NVDA

PHIG

PYPL

SMCI

SOFI

TMUS

월요일(3일) 미국 증시는 도널드 트럼프 대통령이 전면적인 새로운 관세를 발표하면서 급격한 매도세를 보였고, 지난주 손실이 확대되며 모든 주요 섹터가 하락세를 보였다. 

트럼프 관세로 인한 시장 매도세 속 기술 부문 큰 타격...엔비디아·슈퍼마이크로·ARM 급락

PHI Group Inc

<a href="https://www.businesswire.com/news/home/20250304339415/en/" title="https://www.businesswire.com/news/home/20250304339415/en/">https://www.businesswire.com/news/home/20250304339415/en/</a>
&nbsp;
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.edf-re.com&amp;esheet=54218888&amp;newsitemid=20250304339415&amp;lan=en-US&amp;anchor=EDF+Renewables+North+America&amp;index=1&amp;md5=228dd0a0d78a26aae913214dc5145168">EDF Renewables North America</a> and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.masdar.ae&amp;esheet=54218888&amp;newsitemid=20250304339415&amp;lan=en-US&amp;anchor=Abu+Dhabi+Future+Energy+Company+%26%238211%3B+Masdar&amp;index=2&amp;md5=26329b6088cf8c3f9a2fbb2dedf0bc26">Abu Dhabi Future Energy Company – Masdar</a>, <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.edf-re.com%2Fpress-release%2Fmasdar-and-edf-renewables-agree-to-partner-in-eight-renewable-energy-projects-in-united-states%2F&amp;esheet=54218888&amp;newsitemid=20250304339415&amp;lan=en-US&amp;anchor=co-owners+of+the+Las+Majadas+Wind+Project&amp;index=3&amp;md5=3cb08e6db95a484f6e677d68f7fdca4a">co-owners of the Las Majadas Wind Project</a>, have entered into a power purchase agreement (PPA) with data center developer and operator Soluna Holdings, Inc. (Soluna), (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>).
&nbsp;
Under the terms of the agreement, Soluna will purchase up to 166 megawatts (MW) of energy produced by the Las Majadas Wind Project to power a Soluna data center to be built close to the wind project's substation.

Contracts

SLNH

EDF Renewables North America And Masdar Agrees To Power Purchase Agreement With Soluna Holdings

Raymond James analyst Andrew Marok maintains Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) with a Outperform and lowers the price target from $30 to $27.

Price Target

Analyst Ratings

Raymond James Maintains Outperform on Viant Technology, Lowers Price Target to $27

Twilio enables Cedar to streamline communications, elevating patient service and reducing provider costs with AI-driven automation and empathetic support
Twilio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>), the customer engagement platform that drives real-time, personalized experiences for leading brands, and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cedar.com%2F%3Futm_source%3Dpress-release%26utm_medium%3Dpr%26utm_campaign%3DPR%26utm_content%3Dwp&amp;esheet=54218435&amp;newsitemid=20250304590428&amp;lan=en-US&amp;anchor=Cedar&amp;index=1&amp;md5=0bb07910cc48cc4294df65019a542dd5">Cedar</a>, the leading patient financial experience platform for healthcare providers, today announced Twilio is powering Cedar's patient communications across SMS and Voice, including via Twilio's AI-powered ConversationRelay service, with the goals of improving the patient financial experience, driving operational efficiency and delivering cost reduction.
Navigating healthcare bills can be overwhelming, particularly for patients managing multiple providers or facing the burden of being uninsured. Simultaneously, healthcare providers are inundated with thousands of daily inquiries from patients seeking clarity on their financial obligations, driving up administrative costs. Cedar is addressing this systemic challenge by leveraging Twilio's scalable communications technology, seamlessly integrating it into its platform to enhance accessibility, streamline patient interactions, and create a more intuitive financial experience—while also reducing operational expenses for providers.
Cedar is leveraging Twilio's flexible and innovative solutions to build an AI-powered patient financial experience, including:
<ul>
<li>Streamlined Communication: Cedar utilizes Twilio's SMS capabilities to enhance bill notifications and appointment reminders, ensuring patients receive timely and effective updates.</li>
<li>Seamless Payment Experience: By integrating Twilio's Voice API and Stripe Pay Connector, Cedar enables patients to make secure payments over the phone with interactive voice response (IVR), including support for Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA). With <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ebri.org%2Fhealth%2Fcontent%2Fvital-statistics-on-flexible-spending-accounts--2022--forfeitures-on-the-rise&amp;esheet=54218435&amp;newsitemid=20250304590428&amp;lan=en-US&amp;anchor=roughly+half+of+FSA+account+holders+forfeiting+funds&amp;index=2&amp;md5=3442c7b8a59c2b9c859ab57404e2ebf1">roughly half of FSA account holders forfeiting funds</a> due to lack of awareness, this will help patients maximize available resources.</li>
<li>Smart and Personalized Patient Support: Built on Twilio's ConversationRelay service, Cedar later this year will be able to automate inbound patient billing calls with AI-powered voice agents that provide quick answers, reduce wait times, and improve satisfaction.</li>
</ul>
Twilio's ConversationRelay service, which enables developers to create robust natural voice AI agents by seamlessly integrating real-time streaming, speech recognition, and interruption handling, will support HIPAA-eligible use cases in the coming weeks for healthcare providers.

TWLO

Twilio Collaborates With Cedar to Enhance Patient Service And Reduce Costs Through AI-Driven Communication Tools

With latest transaction, Wellvana supports primary care providers across 40 states, serving approximately 1 million patients.
NASHVILLE, Tenn., and WOONSOCKET, R.I., March 4, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4375063-1&amp;h=266419207&amp;u=http%3A%2F%2Fwww.wellvana.com%2F&amp;a=Wellvana">Wellvana</a> and CVS Health&#xAE; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) today announced that Wellvana has acquired the Medicare Shared Savings Program (MSSP) business of CVS Accountable Care&#x2122;, part of CVS Health, in an all-stock transaction, giving CVS Health a strategic minority investment in Wellvana.&nbsp;

Asset Sales

CVS Health Announces That Wellvana Has Acquired The Medicare Shared Savings Program Business Of CVS Accountable Care, Part Of CVS Health, In An All-Stock Transaction; Detailed Terms Have Not Been Disclosed

Citigroup analyst Paul Diamond maintains Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) with a Buy and lowers the price target from $14.5 to $12.

TALO

Citigroup Maintains Buy on Talos Energy, Lowers Price Target to $12

Shares of On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) were rising in early trading on Tuesday, after the company reported <a href="https://www.benzinga.com/25/03/44105269/performance-sportswear-maker-ons-q4-sales-jump-on-increased-brand-awareness-stocks-rise">strong fourth-quarter sales growth</a>.
Here are some key analyst takeaways.
<ul>
<li>Telsey Advisory Group <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f9ab74825a7ef0001015b59/cristina-fernandez">analyst Cristina Fernández</a> maintained an Outperform rating and price target of $67.</li>
<li>Needham <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846ee56ee7bf6000154d12e/tom-nikic">analyst Tom Nikic</a> reaffirmed a Buy rating and price target of $67.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Telsey Advisory Group: The company ended 2024 on a strong note. All metrics came in slightly above expectations. The company expects its revenue growth in 2025 to be frontend-loaded, Fernández said in the note. The company's fourth-quarter sales growth of 36% came in higher than consensus of 33%. Gross margins surged to a record high of 62.1%, she added.
While management's 2025 revenue and gross margin guidance came in slightly short of expectations, the company "tends to provide guidance it can exceed," the analyst stated.
"In addition, On commented 2025 is off to a good start and given the timing of product launches, such as Cloud 6 in February, expects 1H25 revenue growth to be higher than in 2H25," she further wrote.
Needham: With strong product innovation in 2024, On Holding is gearing up for a slew of product launches in 2025. This could drive sales, Nikic said. The company's brand awareness has grown, he added.
On Holding has "increasingly become a sneaker of choice for Gen Z consumers," he added.
Although the EMEA (Europe, the Middle East and Africa) region grew sluggishly through most of 2024, sales growth here accelerated from 15% in the third quarter to 33% in the fourth quarter, the analyst stated. "ONON remains one of the highest-momentum names in our coverage, and we remain bullish based on growing brand awareness, distribution expansion (both in DTC and wholesale), a strong margin profile, and a cash-rich balance sheet," he further wrote.
ONON Price Action: Shares of On Holding had risen by3.26% to $49.41 at the time of publication on Tuesday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44071957/us-stocks-likely-to-open-higher-as-wall-street-watches-trutariff-talks-march-april-may-tend-to-be-solid-months-in-post-election-years-says-expert">Market Momentum: 3 Stocks Poised for Significant Breakouts</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings Beats

Reiteration

Movers

Trading Ideas

ONON

On Holding Posts Record High Q4 Margins, Analyst Praises Gen Z's 'Sneaker Of Choice'

Deep-pocketed investors have adopted a bearish approach towards Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 109 extraordinary options activities for Goldman Sachs Group. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 53% bearish. Among these notable options, 55 are puts, totaling $5,655,452, and 54 are calls, amounting to $3,798,684.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $210.0 to $800.0 for Goldman Sachs Group over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Goldman Sachs Group's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Goldman Sachs Group's whale trades within a strike price range from $210.0 to $800.0 in the last 30 days. 
<h3>Goldman Sachs Group Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741107677_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$63.45</td>
<td>$62.55</td>
<td>$63.0</td>
<td>$580.00</td>
<td>$233.1K</td>
<td align="right">441</td>
<td align="right">374</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$15.25</td>
<td>$13.75</td>
<td>$13.75</td>
<td>$340.00</td>
<td>$171.8K</td>
<td align="right">5</td>
<td align="right">214</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$24.65</td>
<td>$24.2</td>
<td>$24.56</td>
<td>$525.00</td>
<td>$159.8K</td>
<td align="right">220</td>
<td align="right">65</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$49.15</td>
<td>$47.05</td>
<td>$49.15</td>
<td>$600.00</td>
<td>$152.3K</td>
<td align="right">162</td>
<td align="right">32</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$29.0</td>
<td>$28.85</td>
<td>$29.0</td>
<td>$575.00</td>
<td>$150.8K</td>
<td align="right">141</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Goldman Sachs Group</h3>
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
After a thorough review of the options trading surrounding Goldman Sachs Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Goldman Sachs Group Standing Right Now?</h3>
<ul>
<li>With a volume of 1,885,086, the price of GS is down -5.33% at $573.0. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 41 days.</li>
</ul>
<h3>What Analysts Are Saying About Goldman Sachs Group</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $720.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Goldman Sachs Group, which currently sits at a price target of $720. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Goldman Sachs Group, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Spotlight on Goldman Sachs Group: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bearish stance on Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMGN, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Amgen.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 50%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $67,500, and 10 are calls, for a total amount of $496,525.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $260.0 to $340.0 for Amgen over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Amgen's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale activity within a strike price range from $260.0 to $340.0 in the last 30 days. 
<h3>Amgen Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741107671_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$19.35</td>
<td>$18.35</td>
<td>$18.79</td>
<td>$300.00</td>
<td>$94.6K</td>
<td>1.1K</td>
<td align="right">55</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$23.6</td>
<td>$21.2</td>
<td>$21.87</td>
<td>$297.50</td>
<td>$91.8K</td>
<td>12.1K</td>
<td align="right">42</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$66.55</td>
<td>$64.8</td>
<td>$64.8</td>
<td>$260.00</td>
<td>$64.8K</td>
<td>171</td>
<td align="right">10</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$22.25</td>
<td>$20.95</td>
<td>$21.75</td>
<td>$340.00</td>
<td>$43.5K</td>
<td>125</td>
<td align="right">20</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$16.75</td>
<td>$16.5</td>
<td>$16.5</td>
<td>$320.00</td>
<td>$41.2K</td>
<td>2.0K</td>
<td align="right">28</td>
</tr>
</tbody>
</table>

<h3>About Amgen</h3>
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
<h3>Where Is Amgen Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,336,050, the price of AMGN is up by 1.95%, reaching $316.85.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 58 days from now.</li>
</ul>
<h3>What The Experts Say On Amgen</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $302.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Amgen, targeting a price of $329. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Underperform rating on Amgen with a target price of $275. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

AMGN

Behind the Scenes of Amgen's Latest Options Trends

Financial giants have made a conspicuous bullish move on Lemonade. Our analysis of options history for Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) revealed 10 unusual trades.
Delving into the details, we found 60% of traders were bullish, while 20% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $337,085, and 5 were calls, valued at $281,488.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $75.0 for Lemonade during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Lemonade's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Lemonade's significant trades, within a strike price range of $30.0 to $75.0, over the past month.
<h3>Lemonade Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741107665_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/28/25</td>
<td>$12.2</td>
<td>$11.8</td>
<td>$12.0</td>
<td>$45.00</td>
<td>$180.0K</td>
<td>150</td>
<td align="right">150</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$7.5</td>
<td>$7.4</td>
<td>$7.4</td>
<td>$75.00</td>
<td>$133.2K</td>
<td>1.4K</td>
<td align="right">172</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$12.2</td>
<td>$11.8</td>
<td>$12.0</td>
<td>$42.00</td>
<td>$60.0K</td>
<td>61</td>
<td align="right">50</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$6.6</td>
<td>$6.4</td>
<td>$6.5</td>
<td>$50.00</td>
<td>$52.0K</td>
<td>328</td>
<td align="right">242</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$7.4</td>
<td>$7.4</td>
<td>$7.4</td>
<td>$35.00</td>
<td>$37.0K</td>
<td>402</td>
<td align="right">85</td>
</tr>
</tbody>
</table>

<h3>About Lemonade</h3>
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
After a thorough review of the options trading surrounding Lemonade, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Lemonade's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,126,702, the price of LMND is down by -5.9%, reaching $33.64.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 56 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Lemonade</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $47.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Citizens Capital Markets downgraded its rating to Market Outperform, setting a price target of $60. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Lemonade, maintaining a target price of $34. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lemonade options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

LMND

This Is What Whales Are Betting On Lemonade

IPOs

Skycorp Solar Group Shares Open For Trade At $3.69/Share; IPO Priced At $4/Share On 2M Shares

WIIM

Gold is trading higher amid market weakness due to tariff risks, which may be prompting investors to gravitate towards the safe haven asset.

Skycorp Solar Group IPO Indicating $3.69 On 96,018 Shares; IPO Priced At $4/Share On 2M Shares

Citigroup analyst Yigal Nochomovitz maintains Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) with a Buy and lowers the price target from $45 to $42.

SNDX

Citigroup Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $42

Remember the home-buying frenzy and bidding wars of 2021? In many parts of the country, those have disappeared into the rearview mirror as home buyers find the real estate market has finally flipped in their favor, according to new data from<a href="https://www.redfin.com/news/buyers-market-february-2025/"> Redfin</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>).
<h2 class="wp-block-heading">New Homes Sales Down 2%</h2>
Due to increased supply, new homes are now transacting for nearly 2% less than the listing price. In January, inventory was up by 5% over the same time last year, and in some markets, listings are higher than any time over the previous six years. At the same time,<a href="https://www.marketwatch.com/story/existing-home-sales-sag-under-weight-of-7-mortgage-rates-in-first-month-of-2025-5cd8679f?mod=pship_realtor"> high prices and high interest rates have lessened the demand</a>, which has also contributed to turning the market from a seller's to a buyer's.&nbsp;
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a></li>
<li>Many don&#8217;t know there are tax benefits when buying a unit as an investment —<a href="https://www.benzinga.com/money/casa-shares-y2"> Here&#8217;s how to invest in real estate by mirroring BlackRock's big move</a></li>
</ul>
<h2 class="wp-block-heading">Key Findings In Redfin's Data</h2>
<ul>
<li>Sluggish sales: Homes in contract by 6.3% to the lowest figure since the early days of the pandemic</li>
<li>Listings sitting longer: Homes that sold in January had been on the market an average of 56 days — the longest period since 2020.</li>
<li>Home price growth is slowing down: The median home price appreciation in 2024 was 4.1%, which hadn't been experienced in over five years.</li>
<li>Sellers are more willing to negotiate: In January, homes sold on average for 1.8% less than the asking price.</li>
<li>Deals are failing to close: Deals were canceled in January at the highest rate since at least 2017.</li>
</ul>
"Historically, a buyer's market has been defined as when months of supply reaches 4-6 months—but old definitions don't fit the reality of today's market," said <a href="https://www.benzinga.com/real-estate/25/02/43845852/is-the-sunshine-worth-the-price-premium-todays-homebuyers-in-la-sf-and-sd-spend-almost-78-of-their-income-on-mortgage-payments">Redfin</a> Economics Research Lead<a href="https://www.redfin.com/news/author/chen-zhao/"> Chen Zhao</a>. "Many buyers don't feel like they are in a buyer's market, with home prices at near-record highs and mortgage rates elevated. But we are more than halfway through the decade, and this is the first time we can say that buyers have as much, if not more, power than sellers."
Trending: This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.
<h2 class="wp-block-heading">A Tale Of Two Markets</h2>
New home construction has occurred in the <a href="https://www.benzinga.com/real-estate/24/06/39127331/newly-arrived-californians-getting-blamed-for-worsening-this-sunbelt-citys-homeless-crisis">Sunbelt</a> much faster than anywhere else; according to <a href="https://constructioncoverage.com/research/cities-investing-most-in-new-housing">Construction Coverage</a>, the top ten states with the most homes include <a href="https://www.benzinga.com/real-estate/25/01/42872680/texas-hold-em-some-of-texass-top-housing-markets-have-stopped-growing-heres-why">Texas,</a> North Carolina, Florida, Tennessee, and Arizona, some of which appear multiple times. The abundance of new construction has turned the Sunbelt into a buyer's market. Florida is particularly favorable to new buyers because the construction boom there failed to account for increased house prices, the fear of natural disasters, and increased insurance costs, causing buyers to press pause.
"It's 100% a buyer's market right now," said<a href="https://www.redfin.com/real-estate-agents/bryan-carnaggio"> Bryan Carnaggio</a>, a Redfin agent in Jacksonville, Florida. "There's a ton of inventory. Everywhere you go, there's a house for sale. Most sellers here know the market is bad and it's not advantageous to sell right now, but either they're tired of waiting for things to improve, or they really have to sell because they are moving out of state. For buyers, this means there are more opportunities to negotiate on price and terms."&nbsp;
Conversely, Northeast sellers still have the upper hand in some markets. According to<a href="https://blog.altosresearch.com/the-two-big-housing-market-trends-to-watch-in-2025"> Altos Research</a>, the Northeast lacked markedly in inventory at the end of 2024 compared to the Sunbelt. However, inventory levels are expected to even out in 2025, which<a href="https://www.housingwire.com/articles/2025-could-be-the-last-year-of-inventory-shortage/"> HousingWire.com</a> predicts could be the last year of an inventory shortage.&nbsp;
Read Next:
<ul>
<li>CEO of Integris gathered a team of senior investment managers who have $34.22 billion in combined owned and managed assets in the West Coast —<a href="https://www.benzinga.com/money/integris"> here&#8217;s how to invest in their private credit fund that targets 12% annual interest rate.</a></li>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
</ul>

Real Estate

RDFN

Sellers Are Getting Desperate, Flipping U.S. Real Estate Into A Buyers Market, Redfin says

Beacon's Board of Directors Continues to Reiterate Unanimous Recommendation That Beacon Shareholders NOT Tender Their Shares Into QXO's Offer
Beacon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NASDAQ">BECN</a>) (the "Company") today issued the following statement regarding QXO, Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NYSE">QXO</a>) second extension of its unsolicited tender offer to acquire all outstanding shares of Beacon common stock for $124.25 per share in cash (the "Offer"):
For a second time, QXO has extended an Offer that represents an opportunistic attempt to take advantage of the current macro environment and acquire Beacon at a discount to its intrinsic value for the benefit of QXO but the detriment of Beacon's shareholders.
Beacon has repeatedly offered to engage with QXO to demonstrate the additional value for which QXO's initial offer does not fairly compensate our shareholders.
<ul>
<li>We have offered to do this on the standard terms regularly agreed to in such cases.</li>
<li>When QXO objected to those terms, we offered to engage on radically buyer-friendly terms, which included preserving QXO's ability to run a proxy contest at our 2025 Annual Meeting if confidential discussions could not close the valuation gap.</li>
<li>QXO repeatedly stated it was not interested in receiving any confidential information about the Company and its business.</li>
</ul>

Management

BECN

Beacon Issues Statement In Response To QXO's Second Extension Of Unsolicited Tender Offer; Beacon's Board Of Directors Continues To Reiterate Unanimous Recommendation That Beacon Shareholders Not Tender Their Shares Into QXO's Offer

Citigroup analyst Fatima Boolani maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Neutral and raises the price target from $100 to $110.

OKTA

Citigroup Maintains Neutral on Okta, Raises Price Target to $110

FYBR

Verizon CFO Expects To See Around 27M-28M Homes Passed After Frontier Deal Closes

Piper Sandler analyst Jessica Tassan maintains Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) with a Overweight and raises the price target from $14 to $21.

ALHC

Piper Sandler Maintains Overweight on Alignment Healthcare, Raises Price Target to $21

Piper Sandler analyst David Westenberg maintains Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) with a Neutral and lowers the price target from $70 to $55.

Piper Sandler Maintains Neutral on Tempus AI, Lowers Price Target to $55

Loop Capital analyst Rob Sanderson downgrades DoubleVerify Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) from Buy to Hold and lowers the price target from $24 to $16.

Downgrades

Loop Capital Downgrades DoubleVerify Hldgs to Hold, Lowers Price Target to $16

PHI Group

월요일(3일) 미국 증시는 도널드 트럼프 대통령이 전면적인 새로운 관세를 발표하면서 급격한 매도세를 보였고, 지난주 손실이 확대되며 <a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying">모든 주요 섹터</a>가 하락세를 보였다.
무슨 일 있었나: SPDR S&amp;P 500(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)이 추적하는 S&amp;P 500 지수는 1.76% 하락한 5,849.72포인트로 마감하며 2월 24일 5,983포인트에서 하락세를 이어갔다. Invesco QQQ Trust, Series 1(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)가 추적하는 나스닥 100 지수는 일주일 전 21,352포인트에서 20,425.58포인트로 하락하며 최근 고점에서 큰 폭의 조정을 보였다.
특히 기술주가 매도세의 가장 큰 피해를 입었다. 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)는 8.63% 급락했고, ARM 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>)는 8.05% 하락했다. 이미 2월 24일에서 28일 사이에 앱러빈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>)이 20.64% 하락하고 슈퍼마이크로컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)가 19.67% 하락한 잔인했던 한 주 이후에 나타난 것이다.
그러나 벤징가 주식 히트 맵에 따르면 광범위한 시장 매도세 속에서도 일부 주식은 긍정적인 성과를 보였다.
화학 및 관련 제품 분야에서 일라이 릴리(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)는 0.83% 상승했고, 프록터앤드갬블(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>)과 존슨앤드존슨(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>)도 소폭 상승했다. 필립 모리스 인터내셔널(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>)은 2.33% 상승했다. 통신 분야에서는 T-모바일(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>)과 버라이즌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>)이 각각 1.5% 이상 상승했다. 항공 운송에서는 PHI 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIG#NASDAQ">PHIG</a>)이 2.3% 상승했다. 한편 코카콜라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>)와 펩시코(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) 모두 1.3% 이상 상승했다.
<figure class="wp-block-image size-large"><img decoding="async" class="wp-image-807304" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04011143/Screenshot-2025-03-04-at-11.40.56%E2%80%AFAM-1024x590.png" alt="" /></figure>
산업재 섹터도 상당한 압박을 받았다. 버티브 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>)는 10.09% 하락했고, FTAI 에비에이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>)은 7.89% 하락했다. 헬스케어 분야에서는 비원 메디슨스가 10.10% 하락했고, 힘스 앤 허스 헬스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>)는 9.77% 하락했다.
금융 섹터도 예외는 아니었다. 로빈후드 마켓츠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>)는 6.51% 하락했고, 소파이 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>)는 6.40% 하락했다. 이 하락은 지난주 페이팔 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>)가 이미 5.58% 하락한 추세를 이어간 것이다.
소비재와 필수소비재 섹터 모두 하락했다. 리오토(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>)는 10.96% 급락했고, 달러 트리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>)는 6.02% 하락했다. 에너지 주식인 오빈티브(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>)는 8.65% 하락했고, 유틸리티 주식인 비스트라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>)와 콘스텔레이션 에너지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>)는 각각 7.40% 하락했다.
왜 중요한가: 월요일 매도세의 촉매제는 트럼프가 캐나다와 멕시코 수입품에 대한 25% 관세와 중국 제품에 대한 추가 20% 관세를 발표한 것이었다. 코베이시 레터는 관세 인상으로 인해 미국의 평균 실효 관세가 <a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying" target="_blank" rel="noopener">대공황 이후 볼 수 없었던 수준인 약 20%로 인상</a>될 것이라고 지적했다.
펀드스트랫의 시장 전략가 톰 리는 이번 주가 <a href="//www.benzinga.com/markets/equities/25/03/44072005/tom-lee-sees-stocks-potentially-hitting-first-half-lows-this-week-bad-news-has-gotten-priced-in"" target="_blank" rel="noopener">2025년 상반기</a> 증시의 바닥이 될 수 있다며 "많은 악재가 가격에 반영됐다"고 지적하고 투자 심리가 2022년 가을과 비슷한 약세 수준에 도달했다고 말했다.
월스트리트는 여전히 관세의 영향에 대해 의견이 분분한 가운데, 피터 쉬프가 국내 경제 피해를 경고한 반면 앤서니 폼플리아노 같은 다른 사람들은 관세가 <a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying" target="_blank" rel="noopener">국내 제조업</a>을 부양할 수 있다는 증거로 TSMC(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)1천억 달러 미국 투자 발표를 지적했다.
이미지 출처: Shutterstock
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 생성되었으며, Benzinga 편집자가 검토하고 게시했습니다.
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

PHI Group

뉴스

에 대한 최신 뉴스 PHI Group (OTC:PHIG) 주식

화요일, 3월 04, 2025

뉴스

파트너 / 기고자

벤징가 글로벌